scholarly journals A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancer

2014 ◽  
Vol 25 (11) ◽  
pp. 2156-2162 ◽  
Author(s):  
S. Novello ◽  
B. Besse ◽  
E. Felip ◽  
F. Barlesi ◽  
J. Mazieres ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Randomized Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

Phase II Trial of Irinotecan plus Cisplatin Combination as First Line Therapy for Patients with Small cell Lung Cancer

2006 ◽  
Vol 60 (1) ◽  
pp. 57 ◽  
Author(s):  
Hye Cheol Jeong ◽  
Sang Yeub Lee ◽  
Jung Ha Kim ◽  
Eun Sil Ha ◽  
Jin Yong Jung ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

Phase II Study of Irinotecan Plus Cisplatin as First Line therapy in Extensive Small-Cell Lung Cancer

2006 ◽  
Vol 61 (2) ◽  
pp. 143
Author(s):  
Ki Eun Hwang ◽  
So Young Kim ◽  
Jong Hoon Jung ◽  
Seong Hoon Park ◽  
Jung Hyun Park ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy
Sign in / Sign up

Export Citation Format

Share Document